TY - JOUR
T1 - Patients with premature coronary artery disease who carry the ABCC6 R1141X mutation have no Pseudoxanthoma Elasticum phenotype
AU - Wegman, J.J.
AU - Hu, X.
AU - Tan, H.
AU - Bergen, AA
AU - Trip, M.D.
AU - Kastelein, J.J.
AU - Smulders, Y.M.
PY - 2005
Y1 - 2005
N2 - Background: Pseudoxanthoma elasticurn (PXE) is an inherited disorder of elastic tissue. We recently found that heterozygosity for the frequent (0.8% prevalence in Dutch population) R 1141 X mutation in the PXE gene coding for the ABCC6 transporter, is associated with a fourfold risk of premature coronary artery disease. Yet, it is not clear whether or not heterozygosity for this mutation results in a mild PXE phenotype. The objective of our study was to determine if skin and/or eye abnormalities related to a PXE phenotype could be found in patients with premature coronary artery disease, with and without the R 1141 X mutation. Methods: R1141X mutation carriers with premature coronary artery disease (cases) and patients with premature coronary artery disease with no-or not known-mutation (controls) were studied. Cases and controls were examined for PXE-like skin changes and retinal angioid streaks, peau d'orange or pigment epithelium changes. Results: 7 cases and 31 controls were analysed. In both the mutation-positive and the control group, skin inspection and eye fundus examination did not reveal any dermatological or ocular signs of PXE. Conclusions: Carriers for the ABCC6 R 114 1 X mutation, which is frequent and confers a high risk of premature coronary artery disease, do not commonly have skin or eye abnormalities consistent with a mild PXE phenotype. (c) 2004 Elsevier Ireland Ltd. All rights reserved
AB - Background: Pseudoxanthoma elasticurn (PXE) is an inherited disorder of elastic tissue. We recently found that heterozygosity for the frequent (0.8% prevalence in Dutch population) R 1141 X mutation in the PXE gene coding for the ABCC6 transporter, is associated with a fourfold risk of premature coronary artery disease. Yet, it is not clear whether or not heterozygosity for this mutation results in a mild PXE phenotype. The objective of our study was to determine if skin and/or eye abnormalities related to a PXE phenotype could be found in patients with premature coronary artery disease, with and without the R 1141 X mutation. Methods: R1141X mutation carriers with premature coronary artery disease (cases) and patients with premature coronary artery disease with no-or not known-mutation (controls) were studied. Cases and controls were examined for PXE-like skin changes and retinal angioid streaks, peau d'orange or pigment epithelium changes. Results: 7 cases and 31 controls were analysed. In both the mutation-positive and the control group, skin inspection and eye fundus examination did not reveal any dermatological or ocular signs of PXE. Conclusions: Carriers for the ABCC6 R 114 1 X mutation, which is frequent and confers a high risk of premature coronary artery disease, do not commonly have skin or eye abnormalities consistent with a mild PXE phenotype. (c) 2004 Elsevier Ireland Ltd. All rights reserved
U2 - https://doi.org/10.1016/j.ijcard.2004.07.012
DO - https://doi.org/10.1016/j.ijcard.2004.07.012
M3 - Article
C2 - 15837081
SN - 0167-5273
VL - 100
SP - 389
EP - 393
JO - International journal of cardiology
JF - International journal of cardiology
IS - 3
ER -